Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Javelin Biotech Appoints Jacques Banchereau, Ph D As Chief Scientific Officer

PRIVATEApr 17, 2024•about 2 years ago

Position

Chief Scientific Officer

Company

Javelin Biotech

Jacques Banchereau
WoburnBiotechnology

Description

Javelin Biotech, Inc. is delighted to announce the appointment of Jacques Banchereau, PhD as its Chief Scientific Officer (CSO). Banchereau, an internationally recognized immunologist and molecular biologist, will oversee the company's scientific strategy to drive the development of cutting-edge technology for the modeling of human diseases.

Company Information

Company

Javelin Biotech

Location

Woburn, Massachusetts, United States

About

Javelin Biotech is a leading technology company specializing in human tissue chip platforms for biopharma research. The company focuses on humanizing preclinical drug discovery with a predictive platform that merges human tissue chips with digital twin technology.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Javelin Biotech's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.